Valuation: Revvity, Inc.

Capitalization 10.01B 8.5B 7.85B 7.4B 13.73B 931B 13.96B 91.99B 36.05B 448B 37.55B 36.77B 1,593B P/E ratio 2026 *
30.6x
P/E ratio 2027 * 25.1x
Enterprise value 11.95B 10.15B 9.37B 8.83B 16.39B 1,112B 16.67B 110B 43.04B 535B 44.83B 43.89B 1,902B EV / Sales 2026 *
4.01x
EV / Sales 2027 * 3.63x
Free-Float
99.71%
Yield 2026 *
0.32%
Yield 2027 * 0.32%
1 day+1.63%
1 week-1.03%
Current month+2.19%
1 month+3.53%
3 months-20.42%
6 months-4.76%
Current year-7.46%
1 week 88.82
Extreme 88.82
94.96
1 month 83.65
Extreme 83.65
94.96
Current year 83.48
Extreme 83.48
118.3
1 year 81.36
Extreme 81.36
118.3
3 years 79.5
Extreme 79.5
136.89
5 years 79.5
Extreme 79.5
203.16
10 years 45.35
Extreme 45.35
203.16
Manager TitleAgeSince
Chief Executive Officer 61 30/12/2019
Director of Finance/CFO 37 06/09/2022
Chief Tech/Sci/R&D Officer - 01/05/2023
Director TitleAgeSince
Chairman 68 30/12/2019
Director/Board Member 74 07/02/2012
Director/Board Member 72 27/07/2016
Change 5d. change 1-year change 3-years change Capi.($)
+1.59%-1.03%-4.50%-34.70% 10.01B
+1.57%+3.11%+18.13%-12.37% 192B
+1.75%+0.69%-4.83%+71.55% 163B
+0.48%+0.41%+1.64%-23.00% 137B
+1.20%+3.49%-33.42%+22.50% 94.25B
+1.21%+2.73%-13.12%-27.72% 50.39B
+0.38%-0.13%+11.03%-6.29% 45.58B
+0.90%+2.48%+15.14%-15.05% 33.42B
+2.53%+0.40%+19.06%-11.13% 33.4B
+1.03%-1.43%+6.26%+0.07% 32.59B
Average +1.14%+1.68%+1.54%-3.61% 79.12B
Weighted average by Cap. +1.00%+2.22%+1.15%+6.74%

Financials

2026 *2027 *
Net sales 2.98B 2.53B 2.34B 2.2B 4.09B 277B 4.16B 27.39B 10.73B 133B 11.18B 10.95B 474B 3.13B 2.66B 2.46B 2.32B 4.3B 292B 4.37B 28.8B 11.29B 140B 11.76B 11.51B 499B
Net income 341M 289M 267M 252M 467M 31.7B 475M 3.13B 1.23B 15.25B 1.28B 1.25B 54.23B 410M 348M 322M 303M 563M 38.18B 572M 3.77B 1.48B 18.37B 1.54B 1.51B 65.32B
Net Debt 1.94B 1.65B 1.52B 1.43B 2.66B 181B 2.71B 17.83B 6.99B 86.87B 7.28B 7.13B 309B 1.36B 1.16B 1.07B 1.01B 1.87B 127B 1.9B 12.53B 4.91B 61.05B 5.12B 5.01B 217B
Logo Revvity, Inc.
Revvity, Inc. specializes in designing, manufacturing, and marketing measurement devices and analytical instruments for the healthcare, environmental, scientific research, industry and food sectors. Net sales break down by family of products as follows: - medical diagnosis equipment (50.1%); - analytical tools and instruments (49.9%): biological molecular research tools, thermal analysis software, chemical and environmental measurement tools, genetic screening instruments, reagents, etc. Net sales break down by source of revenue between sales of products (83.7%) and services (16.3%). Net sales are distributed geographically as follows: America (44%), Europe (28.9%) and Asia (27.1%).
Employees
11,000
Date Price Change Volume
17/04/26 89.53 $ -3.63% 1,192,218
15/04/26 92.90 $ -0.65% 550,691
14/04/26 93.51 $ +0.94% 600,617
13/04/26 92.64 $ +3.17% 502,912
10/04/26 89.79 $ -0.74% 658,379
Trader
Investor
Global
Quality
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
18
Last Close Price
89.53USD
Average target price
115.13USD
Spread / Average Target
+28.60%

Quarterly revenue - Rate of surprise